Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Please note this study is not being conducted in the United States. The purpose of this study
is to test the hypothesis that acute DPP-4 inhibition with vildagliptin improves fat and
muscle metabolism in patients with type 2 diabetes mellitus.